Qin J et al. |
Radiological and clinical findings of 25 patients with invasive pulmonary aspergillosis: retrospective analysis of 2150 liver transplantation cases. |
2012 |
Br J Radiol |
pmid:22496071
|
Anoopkumar-Dukie S et al. |
Mitochondrial modulation of oxygen-dependent radiosensitivity in some human tumour cell lines. |
2009 |
Br J Radiol |
pmid:19366737
|
Murphy GJ et al. |
Randomized clinical trial of the effect of microemulsion cyclosporin and tacrolimus on renal allograft fibrosis. |
2003 |
Br J Surg |
pmid:12808614
|
Middleton SJ et al. |
Adult small intestinal transplantation in England and Wales. |
2003 |
Br J Surg |
pmid:12808622
|
Morris-Stiff GJ et al. |
Sequential changes in plasma selenium concentration after cadaveric renal transplantation. |
2004 |
Br J Surg |
pmid:14991636
|
Wilson CH et al. |
Randomized clinical trial of daclizumab induction and delayed introduction of tacrolimus for recipients of non-heart-beating kidney transplants. |
2005 |
Br J Surg |
pmid:15856479
|
Waller JR et al. |
Effects of the combination of rapamycin with tacrolimus or cyclosporin on experimental intimal hyperplasia. |
2002 |
Br J Surg |
pmid:12390379
|
Brook NR et al. |
Fibrosis-associated gene expression in renal transplant glomeruli after acute renal allograft rejection. |
2003 |
Br J Surg |
pmid:12905557
|
Jain S et al. |
Tacrolimus has less fibrogenic potential than cyclosporin A in a model of renal ischaemia-reperfusion injury. |
2000 |
Br J Surg |
pmid:11091246
|
Bicknell GR et al. |
Differential effects of cyclosporin and tacrolimus on the expression of fibrosis-associated genes in isolated glomeruli from renal transplants. |
2000 |
Br J Surg |
pmid:11091247
|
White DJ |
Immunosuppression for heart transplantation. |
1993 |
Br. J. Biomed. Sci. |
pmid:7694717
|
Reichert TE et al. |
The role of endogenous interleukin-2 in proliferation of human carcinoma cell lines. |
1999 |
Br. J. Cancer |
pmid:10555752
|
Andersson Y et al. |
Synergistic anti-cancer effects of immunotoxin and cyclosporin in vitro and in vivo. |
2009 |
Br. J. Cancer |
pmid:19773757
|
Chambers CA |
Topical tacrolimus for cutaneous lupus erythematosus. |
2003 |
Br. J. Dermatol. |
pmid:12752154
|
Ludwig E et al. |
New treatment modalities for granuloma faciale. |
2003 |
Br. J. Dermatol. |
pmid:14511001
|
Vecchietti G et al. |
Topical tacrolimus (FK506) for relapsing erosive stomatitis in paraneoplastic pemphigus. |
2003 |
Br. J. Dermatol. |
pmid:12752158
|
Patel NP et al. |
Treatment of eosinophilic pustulosis of infancy with topical tacrolimus. |
2012 |
Br. J. Dermatol. |
pmid:22563626
|
Aoyama H et al. |
Successful treatment of resistant facial lesions of atopic dermatitis with 0.1% FK506 ointment. |
1995 |
Br. J. Dermatol. |
pmid:8547017
|
Meingassner JG et al. |
Pimecrolimus does not affect Langerhans cells in murine epidermis. |
2003 |
Br. J. Dermatol. |
pmid:14616380
|
Wilsmann-Theis D et al. |
Successful treatment of acrodermatitis continua suppurativa with topical tacrolimus 0.1% ointment. |
2004 |
Br. J. Dermatol. |
pmid:15214910
|
Lerbaek A and Agner T |
Facial eruption of molluscum contagiosum during topical treatment of atopic dermatitis with tacrolimus. |
2004 |
Br. J. Dermatol. |
pmid:15214914
|
Edmonds EV et al. |
Nodular prurigo responding to topical tacrolimus. |
2004 |
Br. J. Dermatol. |
pmid:15214918
|
Murrell DF et al. |
A randomized controlled trial of pimecrolimus cream 1% in adolescents and adults with head and neck atopic dermatitis and intolerant of, or dependent on, topical corticosteroids. |
2007 |
Br. J. Dermatol. |
pmid:17935515
|
Liao YH et al. |
Comparison of cutaneous tolerance and efficacy of calcitriol 3 microg g(-1) ointment and tacrolimus 0.3 mg g(-1) ointment in chronic plaque psoriasis involving facial or genitofemoral areas: a double-blind, randomized controlled trial. |
2007 |
Br. J. Dermatol. |
pmid:17935517
|
Sugiura H et al. |
An open study of a lotion formulation to improve tolerance of tacrolimus in facial atopic dermatitis. |
2001 |
Br. J. Dermatol. |
pmid:11736904
|
Wu CS et al. |
FK506 inhibits the enhancing effects of transforming growth factor (TGF)-β1 on collagen expression and TGF-β/Smad signalling in keloid fibroblasts: implication for new therapeutic approach. |
2012 |
Br. J. Dermatol. |
pmid:22540338
|
Tennis P et al. |
Evaluation of cancer risk related to atopic dermatitis and use of topical calcineurin inhibitors. |
2011 |
Br. J. Dermatol. |
pmid:21466537
|
Afshar M et al. |
The effect of pimecrolimus on innate immunity in subjects with atopic dermatitis: a double-blind, randomized, vehicle-controlled study. |
2013 |
Br. J. Dermatol. |
pmid:22577776
|
Calza AM and Lübbe J |
Tacrolimus ointment-associated alcohol intolerance in infants receiving ethanol-containing medication. |
2005 |
Br. J. Dermatol. |
pmid:15787832
|
Rigopoulos D et al. |
Pimecrolimus cream 1% vs. betamethasone 17-valerate 0.1% cream in the treatment of seborrhoeic dermatitis. A randomized open-label clinical trial. |
2004 |
Br. J. Dermatol. |
pmid:15541087
|
Clayton TH and Harrison PV |
Successful treatment of chronic ulcerated necrobiosis lipoidica with 0.1% topical tacrolimus ointment. |
2005 |
Br. J. Dermatol. |
pmid:15787840
|
RodrÃguez GarcÃa F et al. |
Generalized pustular psoriasis successfully treated with topical tacrolimus. |
2005 |
Br. J. Dermatol. |
pmid:15787845
|
Danby SG et al. |
The effect of tacrolimus compared with betamethasone valerate on the skin barrier in volunteers with quiescent atopic dermatitis. |
2014 |
Br. J. Dermatol. |
pmid:24328907
|
Weidinger S et al. |
A 5-year randomized trial on the safety and efficacy of pimecrolimus in atopic dermatitis: a critical appraisal. |
2017 |
Br. J. Dermatol. |
pmid:28868633
|
Charman C |
A 5-year randomized trial on the safety and efficacy of pimecrolimus in atopic dermatitis: a critical appraisal - comment. |
2017 |
Br. J. Dermatol. |
pmid:28858382
|
Carroll CL et al. |
Better medication adherence results in greater improvement in severity of psoriasis. |
2004 |
Br. J. Dermatol. |
pmid:15491434
|
Wenzel J et al. |
Successful treatment of recalcitrant Wegener's granulomatosis of the skin with tacrolimus (Prograf). |
2004 |
Br. J. Dermatol. |
pmid:15491443
|
Chung BY et al. |
The proactive treatment of atopic dermatitis with tacrolimus ointment in Korean patients: a comparative study between once-weekly and thrice-weekly applications. |
2013 |
Br. J. Dermatol. |
pmid:23110605
|
Kabashima K et al. |
Treatment of eosinophilic pustular folliculitis (Ofuji's disease) with tacrolimus ointment. |
2004 |
Br. J. Dermatol. |
pmid:15491457
|
Esquivel-Pedraza L et al. |
Treatment of oral lichen planus with topical pimecrolimus 1% cream. |
2004 |
Br. J. Dermatol. |
pmid:15099380
|
Aguilar-Bernier M et al. |
Successful treatment of pruritus with topical tacrolimus in a patient with primary biliary cirrhosis. |
2005 |
Br. J. Dermatol. |
pmid:15840123
|
Sorgentini C et al. |
Lichen striatus in an adult: successful treatment with tacrolimus. |
2004 |
Br. J. Dermatol. |
pmid:15099383
|
Dissemond J et al. |
Pimecrolimus in an adhesive ointment as a new treatment option for oral lichen planus. |
2004 |
Br. J. Dermatol. |
pmid:15099387
|
Harth W and Linse R |
Topical tacrolimus in granuloma annulare and necrobiosis lipoidica. |
2004 |
Br. J. Dermatol. |
pmid:15099394
|
Higgins E and Collins P |
Recurrent bullous erythema multiforme treated with topical tacrolimus 0·1% ointment. |
2011 |
Br. J. Dermatol. |
pmid:21114481
|
Pitt M et al. |
A cost-utility analysis of pimecrolimus vs. topical corticosteroids and emollients for the treatment of mild and moderate atopic eczema. |
2006 |
Br. J. Dermatol. |
pmid:16704646
|
Hashizume H et al. |
Comparable risk of herpes simplex virus infection between topical treatments with tacrolimus and corticosteroids in adults with atopic dermatitis. |
2006 |
Br. J. Dermatol. |
pmid:16704659
|
Simon D et al. |
Successful treatment of pityriasis lichenoides with topical tacrolimus. |
2004 |
Br. J. Dermatol. |
pmid:15149526
|
Mrowietz U et al. |
The novel ascomycin derivative SDZ ASM 981 is effective for psoriasis when used topically under occlusion. |
1998 |
Br. J. Dermatol. |
pmid:9990361
|
Jain S and Stephens CJ |
Successful treatment of disseminated granuloma annulare with topical tacrolimus. |
2004 |
Br. J. Dermatol. |
pmid:15149532
|
Koguchi-Yoshioka H et al. |
Intravenous immunoglobulin contributes to the control of antimelanoma differentiation-associated protein 5 antibody-associated dermatomyositis with palmar violaceous macules/papules. |
2017 |
Br. J. Dermatol. |
pmid:28346662
|
Ghislain PD et al. |
Efficacy and systemic absorption of topical tacrolimus used in pyoderma gangrenosum. |
2004 |
Br. J. Dermatol. |
pmid:15149540
|
Hoeger PH et al. |
The treatment of facial atopic dermatitis in children who are intolerant of, or dependent on, topical corticosteroids: a randomized, controlled clinical trial. |
2009 |
Br. J. Dermatol. |
pmid:19067708
|
Griffiths CE |
Ascomycin: an advance in the management of atopic dermatitis. |
2001 |
Br. J. Dermatol. |
pmid:11298524
|
Fujimoto N et al. |
Facial lichen striatus: successful treatment with tacrolimus ointment. |
2003 |
Br. J. Dermatol. |
pmid:12653755
|
Ueda M et al. |
Successful treatment of amyopathic dermatomyositis with topical tacrolimus. |
2003 |
Br. J. Dermatol. |
pmid:12653761
|
Fricain JC et al. |
Long-term efficacy of topical tacrolimus on oral lesions of chronic graft-versus-host disease. |
2007 |
Br. J. Dermatol. |
pmid:17300261
|
Vissers WH et al. |
Topical treatment of mild to moderate plaque psoriasis with 0.3% tacrolimus gel and 0.5% tacrolimus cream: the effect on SUM score, epidermal proliferation, keratinization, T-cell subsets and HLA-DR expression. |
2008 |
Br. J. Dermatol. |
pmid:18284400
|
Ormerod AD |
Topical tacrolimus and pimecrolimus and the risk of cancer: how much cause for concern? |
2005 |
Br. J. Dermatol. |
pmid:16181449
|
Lan CC et al. |
FK506 inhibits tumour necrosis factor-alpha secretion in human keratinocytes via regulation of nuclear factor-kappaB. |
2005 |
Br. J. Dermatol. |
pmid:16181452
|
Vukmanovic-Stejic M et al. |
Relative impact of CD4+CD25+ regulatory T cells and tacrolimus on inhibition of T-cell proliferation in patients with atopic dermatitis. |
2005 |
Br. J. Dermatol. |
pmid:16181456
|
Martin-Munoz MF et al. |
Topical treatment tacrolimus and food allergy. |
2005 |
Br. J. Dermatol. |
pmid:16181473
|
Nissi R et al. |
Altered p53 and Bcl-2 expression in keratinocytes of vulvar lichen sclerosus during pimecrolimus treatment. |
2009 |
Br. J. Dermatol. |
pmid:19659469
|
Lan CC et al. |
FK506 promotes melanocyte and melanoblast growth and creates a favourable milieu for cell migration via keratinocytes: possible mechanisms of how tacrolimus ointment induces repigmentation in patients with vitiligo. |
2005 |
Br. J. Dermatol. |
pmid:16120133
|
Alomar A et al. |
The role of topical calcineurin inhibitors in atopic dermatitis. |
2004 |
Br. J. Dermatol. |
pmid:15548171
|
Ständer S et al. |
Topical pimecrolimus and tacrolimus transiently induce neuropeptide release and mast cell degranulation in murine skin. |
2007 |
Br. J. Dermatol. |
pmid:17388925
|
Mashayekhi S et al. |
The treatment of vulval lichen sclerosus in prepubertal girls: a critically appraised topic. |
2017 |
Br. J. Dermatol. |
pmid:28244087
|
Reitamo S et al. |
A 4-year follow-up study of atopic dermatitis therapy with 0.1% tacrolimus ointment in children and adult patients. |
2008 |
Br. J. Dermatol. |
pmid:18637898
|
Barbier N et al. |
Validation of the Eczema Area and Severity Index for atopic dermatitis in a cohort of 1550 patients from the pimecrolimus cream 1% randomized controlled clinical trials programme. |
2004 |
Br. J. Dermatol. |
pmid:14746622
|
Rubegni P et al. |
A case of reticular erythematous mucinosis treated with topical tacrolimus. |
2004 |
Br. J. Dermatol. |
pmid:14746650
|
Abe R et al. |
Severe refractory chronic actinic dermatitis successfully treated with tacrolimus ointment. |
2002 |
Br. J. Dermatol. |
pmid:12452891
|
Taher ZA et al. |
Analysis of interleukin-10 levels in lesions of vitiligo following treatment with topical tacrolimus. |
2009 |
Br. J. Dermatol. |
pmid:19438859
|
Lonsdale-Eccles AA and Velangi S |
Topical pimecrolimus in the treatment of genital lichen planus: a prospective case series. |
2005 |
Br. J. Dermatol. |
pmid:16086755
|
Undre NA et al. |
Skin and systemic pharmacokinetics of tacrolimus following topical application of tacrolimus ointment in adults with moderate to severe atopic dermatitis. |
2009 |
Br. J. Dermatol. |
pmid:19076975
|
Bäumer W et al. |
Cilomilast, tacrolimus and rapamycin modulate dendritic cell function in the elicitation phase of allergic contact dermatitis. |
2005 |
Br. J. Dermatol. |
pmid:16029339
|
Caproni M et al. |
The comparative effects of tacrolimus and hydrocortisone in adult atopic dermatitis: an immunohistochemical study. |
2007 |
Br. J. Dermatol. |
pmid:17223872
|
Bilenchi R et al. |
Human papillomavirus reactivation following topical tacrolimus therapy of anogenital lichen sclerosus. |
2007 |
Br. J. Dermatol. |
pmid:17223903
|
Mashiko M et al. |
A case of angiolymphoid hyperplasia with eosinophilia successfully treated with tacrolimus ointment. |
2006 |
Br. J. Dermatol. |
pmid:16536847
|
Wollenberg A et al. |
Economic evaluation of maintenance treatment with tacrolimus 0.1% ointment in adults with moderate to severe atopic dermatitis. |
2008 |
Br. J. Dermatol. |
pmid:18782316
|
Doss N et al. |
Superiority of tacrolimus 0.1% ointment compared with fluticasone 0.005% in adults with moderate to severe atopic dermatitis of the face: results from a randomized, double-blind trial. |
2009 |
Br. J. Dermatol. |
pmid:19416227
|
Thaçi D et al. |
Proactive disease management with 0.03% tacrolimus ointment for children with atopic dermatitis: results of a randomized, multicentre, comparative study. |
2008 |
Br. J. Dermatol. |
pmid:18782319
|
Leung DY et al. |
Effects of pimecrolimus cream 1% in the treatment of patients with atopic dermatitis who demonstrate a clinical insensitivity to topical corticosteroids: a randomized, multicentre vehicle-controlled trial. |
2009 |
Br. J. Dermatol. |
pmid:19416245
|
Hickey JR et al. |
Does topical tacrolimus induce lentigines in children with atopic dermatitis? A report of three cases. |
2005 |
Br. J. Dermatol. |
pmid:15656817
|
Mancuso G and Berdondini RM |
Localized scleroderma: response to occlusive treatment with tacrolimus ointment. |
2005 |
Br. J. Dermatol. |
pmid:15656828
|
Neckermann G et al. |
Atopic dermatitis-like symptoms in hypomagnesaemic hairless rats are prevented and inhibited by systemic or topical SDZ ASM 981. |
2000 |
Br. J. Dermatol. |
pmid:10792216
|
Queille-Roussel C et al. |
The new topical ascomycin derivative SDZ ASM 981 does not induce skin atrophy when applied to normal skin for 4 weeks: a randomized, double-blind controlled study. |
2001 |
Br. J. Dermatol. |
pmid:11260007
|
Ramsay HM and Harden PN |
Cyclosporin-induced flushing in a renal transplant recipient resolving after substitution with tacrolimus. |
2000 |
Br. J. Dermatol. |
pmid:10792253
|
Rao A and Bunker C |
Efficacy and safety of tacrolimus ointment 0.1% vs. betamethasone 17-valerate 0.1% in the treatment of chronic paronychia: an unblinded randomized study. |
2010 |
Br. J. Dermatol. |
pmid:20353455
|
Ellis C et al. |
International Consensus Conference on Atopic Dermatitis II (ICCAD II): clinical update and current treatment strategies. |
2003 |
Br. J. Dermatol. |
pmid:12694268
|
Oji V et al. |
Topical pimecrolimus: a novel therapeutic option for Netherton syndrome. |
2005 |
Br. J. Dermatol. |
pmid:16225628
|
Clayton TH et al. |
Topical tacrolimus for facial psoriasis. |
2003 |
Br. J. Dermatol. |
pmid:12932257
|
Burkhart CG and Burkhart CN |
Tacrolimus and topical steroids: which is more effective? |
2004 |
Br. J. Dermatol. |
pmid:15606537
|
Lee DH et al. |
Pimecrolimus 1% cream for the treatment of steroid-induced rosacea: an 8-week split-face clinical trial. |
2008 |
Br. J. Dermatol. |
pmid:18363758
|
Moreno-Arias GA et al. |
Plasma cell balanitis treated with tacrolimus 0.1%. |
2005 |
Br. J. Dermatol. |
pmid:16307659
|
Tzung TY and Wu JC |
Topical calcineurin inhibitors in treating Jessner's lymphocytic infiltration of the skin: report of a case. |
2005 |
Br. J. Dermatol. |
pmid:15727667
|
Poole CD et al. |
Health-related utility among adults with atopic dermatitis treated with 0.1% tacrolimus ointment as maintenance therapy over the long term: findings from the Protopic CONTROL study. |
2009 |
Br. J. Dermatol. |
pmid:19754867
|
Chu CY |
The use of 1% pimecrolimus cream for the treatment of steroid-induced rosacea. |
2005 |
Br. J. Dermatol. |
pmid:15727676
|
Park CW et al. |
Tacrolimus decreases the expression of eotaxin, CCR3, RANTES and interleukin-5 in atopic dermatitis. |
2005 |
Br. J. Dermatol. |
pmid:15948978
|
Grassberger M et al. |
A novel anti-inflammatory drug, SDZ ASM 981, for the treatment of skin diseases: in vitro pharmacology. |
1999 |
Br. J. Dermatol. |
pmid:10468798
|
Takeuchi S et al. |
Pruritus of patients with atopic dermatitis in daily life and their experience of therapeutic effects: results of a web-based questionnaire survey. |
2015 |
Br. J. Dermatol. |
pmid:25421804
|